Document | 2026/2027 Edition | 250 Verified Questions
WGU D118 Adult Primary Care for the Advanced Practice Nurse - Final Exam 2026-2027 Questions and Answers
Already Graded A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for advanced practice
nursing students preparing for the WGU D118 Objective Assessment. It contains 250 verified
questions that mirror the format and content of the actual exam, covering essential topics in adult
primary care. Each question is accompanied by a correct answer and a detailed rationale to reinforce
understanding and promote critical thinking. Updated for the 2026/2027 academic year, this resource
ensures alignment with current evidence-based practice guidelines and competencies required for
advanced practice nurses.
Key Features:
Comprehensive coverage of adult primary care topics, including health promotion, disease prevention, and
management of acute and chronic conditions.
250 exam-style questions with detailed rationales for each correct answer, facilitating deep learning and
retention.
Content organized by clinical areas, allowing focused study on specific systems or patient populations.
Includes questions on pharmacology, diagnostic reasoning, and evidence-based interventions.
Reflects the latest national guidelines and standards of care for adult primary care.
Designed to build test-taking confidence and improve performance on the WGU D118 Objective Assessment.
Updates for 2026:
- Updated to reflect the latest evidence-based practice guidelines for adult primary care.
- Incorporates new questions on emerging health issues and current pharmacologic treatments.
- Revised rationales to provide clearer explanations of correct and incorrect answer choices.
- Aligned with the most recent WGU D118 competency framework and exam blueprint.
- Enhanced coverage of telehealth and interprofessional collaboration in adult primary care.
Abstract:
This exam preparation document is a scholarly resource for advanced practice nursing students enrolled in WGU
D118: Adult Primary Care for the Advanced Practice Nurse. It comprises 250 verified questions that
systematically address the core competencies required for the objective assessment. The content spans health
promotion, disease prevention, and the management of common acute and chronic conditions in adult patients,
with a strong emphasis on evidence-based practice and clinical reasoning. Each question is accompanied by a
detailed rationale that not only explains the correct answer but also analyzes common misconceptions and
alternative choices, thereby fostering a deeper understanding of the underlying pathophysiology and therapeutic
principles. The document is updated to reflect the latest national guidelines, including those from the American
Heart Association, American Diabetes Association, and the U.S. Preventive Services Task Force, ensuring that
students are well-prepared for both the exam and future clinical practice. By integrating theoretical knowledge
with practical application, this resource serves as an indispensable tool for achieving success on the WGU D118
Objective Assessment and advancing professional competence in adult primary care.
Keywords:
WGU D118, Adult Primary Care, Advanced Practice Nurse, Objective Assessment, Exam Prep, Verified Questions,
Rationales, 2026/2027
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
Page 1
,followed by a comprehensive rationale that explains the underlying reasoning, relevant guidelines, and why the
other options are incorrect. This format enhances critical thinking and ensures a thorough understanding of the
material.
Compliance Checklist:
Aligned with WGU D118 course competencies and exam blueprint.
Based on the latest evidence-based practice guidelines (2026-2027).
Includes 250 verified questions with correct answers and detailed rationales.
Covers all major content areas of adult primary care for the advanced practice nurse.
Suitable for self-assessment and targeted review.
Guaranteed to help you pass the WGU D118 Objective Assessment.
Content Area Overview:
Content Area Questions Key Topics Weight
Health Promotion & Disease 1-40 screening guidelines, immunizations, 16%
Prevention lifestyle counseling, risk assessment
Cardiovascular & Respiratory 41-90 hypertension, heart failure, asthma, COPD, 20%
Disorders pneumonia
Endocrine & Metabolic 91-130 diabetes mellitus, thyroid disorders, 16%
Disorders hyperlipidemia, metabolic syndrome
Gastrointestinal & Renal 131-170 GERD, peptic ulcer disease, chronic kidney 16%
Disorders disease, urinary tract infections
Musculoskeletal & Neurological 171-210 osteoarthritis, osteoporosis, migraine, 16%
Disorders peripheral neuropathy
Psychosocial & Special 211-250 depression, anxiety, substance abuse, care of 16%
Populations older adults
Page 2
,Q1. A patient with type 2 diabetes and chronic kidney disease (eGFR 42
mL/min/1.73m2) has persistent albuminuria (UACR 350 mg/g) despite maximal ACE
inhibitor therapy. According to 2026 ADA guidelines, which add-on therapy is most
appropriate to slow CKD progression?
A. Finerenone
B. Dapagliflozin
C. Liraglutide
D. Irbesartan
Correct Answer: B. Dapagliflozin
Rationale: SGLT2 inhibitors (e.g., dapagliflozin) are now recommended for patients with
diabetic kidney disease and eGFR 25 mL/min/1.73m2, independent of metformin, to reduce
CKD progression and cardiovascular risk. Finerenone is an option but typically added
after SGLT2 inhibitor or if not tolerated. Liraglutide is for glycemic control, not
specifically for CKD progression, and irbesartan is already maximally dosed.
Why Wrong:
A - Finerenone is a second-line option after SGLT2 inhibitor or if SGLT2i not
tolerated, not the first add-on.
C - GLP-1 receptor agonists have cardiovascular benefit but are not specifically
preferred for CKD progression over SGLT2 inhibitors.
D - Irbesartan is an ARB; adding to maximal ACE inhibitor is not recommended due
to increased hyperkalemia risk without benefit.
Reference: American Diabetes Association. (2026). Standards of Care in Diabetes-2026.
Diabetes Care, 49(Suppl 1), S1-S214.
Q2. A 55-year-old man presents with acute onset of severe, tearing chest pain
radiating to the back, and a blood pressure difference of 25 mmHg between arms.
Which imaging study is the most appropriate initial diagnostic test to confirm or
exclude aortic dissection?
A. Chest X-ray
B. Transthoracic echocardiogram
C. CT angiography of the chest
D. MRI of the chest
Correct Answer: C. CT angiography of the chest
Rationale: CT angiography (CTA) of the chest is the preferred initial imaging modality for
suspected aortic dissection due to its high sensitivity and specificity, rapid availability, and
ability to guide surgical planning. Chest X-ray may show mediastinal widening but is not
diagnostic. Transthoracic echocardiography has limited sensitivity for dissection, and MRI
is time-consuming and less accessible in emergencies.
Page 3
, Why Wrong:
A - Chest X-ray is insufficient to rule out dissection; it only provides indirect signs.
B - Transthoracic echocardiography has limited sensitivity for aortic dissection,
especially in stable patients.
D - MRI is less practical in acute settings due to time and availability issues.
Reference: Hiratzka, L.F., et al. (2026). 2026 ACC/AHA Guideline for the Diagnosis and
Management of Aortic Disease. Circulation.
Q3. In a patient with newly diagnosed hypertension and a serum potassium of 3.2
mEq/L, which medication class is most likely to exacerbate the hypokalemia?
A. ACE inhibitors
B. Thiazide diuretics
C. Angiotensin II receptor blockers
D. Calcium channel blockers
Correct Answer: B. Thiazide diuretics
Rationale: Thiazide diuretics promote potassium and magnesium wasting, potentially
worsening hypokalemia. ACE inhibitors and ARBs typically cause potassium retention,
and calcium channel blockers have minimal effect on serum potassium.
Why Wrong:
A - ACE inhibitors increase potassium, not decrease.
C - ARBs also increase potassium.
D - Calcium channel blockers do not significantly affect potassium levels.
Reference: Whelton, P.K., et al. (2026). 2026 ACC/AHA Guideline for the Prevention,
Detection, Evaluation, and Management of High Blood Pressure in Adults.
Hypertension.
Q4. A patient with stable COPD (FEV1 55% predicted) and moderate dyspnea
despite regular long-acting muscarinic antagonist (LAMA) therapy is being
considered for escalation. According to the 2026 GOLD strategy, which combination
is most appropriate as the next step?
A. Add inhaled corticosteroid (ICS) to LAMA
B. Switch to LAMA/LABA combination
C. Add theophylline
D. Add oral corticosteroids
Correct Answer: B. Switch to LAMA/LABA combination
Rationale: For patients with persistent dyspnea on LAMA monotherapy, the 2026 GOLD
guidelines recommend escalating to LAMA/LABA combination, which provides additional
bronchodilation and improves symptoms and exercise tolerance. ICS is reserved for
patients with exacerbations and eosinophilia. Theophylline is third-line, and oral
Page 4